Targeting astrocytic Dp71 attenuates BBB disruption after traumatic brain injury through WTAP-associated m 6 A regulation of MMP2
Science Advances · 03.07.2026 · 12 (27)
DOI: 10.1126/sciadv.aed8653 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 03.07.2026. Verfasst von Jiheng Wang und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Tangdu Hospital, Fourth Military Medical University, Xi'an, 710038 Shaanxi, China. Hauptthemen laut MEDLINE: Astrocytes, Brain Injuries, Traumatic, Matrix Metalloproteinase 2, Blood-Brain Barrier. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Blood-brain barrier (BBB) disruption is a major pathological feature of traumatic brain injury (TBI) that contributes to secondary damage and poor neurological recovery. Although astrocytes are essential for BBB homeostasis, the molecular basis of astrocyte-associated BBB dysfunction after TBI remains unclear. Here, we found that astrocytic dystrophin protein 71 (Dp71) expression was reduced after TBI in both patients and mouse models. In mice, further experimental down-regulation of astrocytic Dp71 attenuated secondary BBB disruption and was accompanied by reduced astrocyte activation, inflammatory cell infiltration, and matrix metalloproteinase-2 (MMP2) release. Mechanistically, nuclear Dp71 interacted with Wilms tumor 1–associated protein (WTAP) and influenced its ubiquitination, leading to changes in the N 6 -methyladenosine (m 6 A) modification, RNA stability, and expression of MMP2 messenger RNA. In addition, biomimetic nanovesicles coated with astrocyte membranes enabled targeted delivery of small interfering RNA targeting Dp71 (siDp71) to astrocytes and reduced MMP2 release and BBB damage after TBI, suggesting a potential therapeutic strategy for mitigating BBB injury after TBI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Tangdu Hospital, Fourth Military Medical University, Xi'an, 710038 Shaanxi, China.
- Medical School, Northwest University, Xi'an, 710068 Shaanxi, China.
- Laboratory of Gene Therapy, Department of Biochemistry, College of Life Sciences, Shaanxi Normal University, Xi'an, 710062 Shaanxi, China.
- Department of Neurosurgery, The First Affiliated Hospital of Shandong First Medical University, Jinan 250014, China.
- Department of Neurosurgery, Shandong Provincial Hospital, Shandong First Medical University, Jinan 250021, China.
ORCID-Profile: Jiheng Wang, Chenzhu Zhao, Bei Liu, Yuankun Chen, Wenxing Cui, Tao Xin, Xun Wu, Shunnan Ge, Dayun Feng, Yan Qu, Tianzhi Zhao
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wang, J., Zhao, C., Liu, B., Wang, Z., Hou, Y., Chen, Y., Cui, W., Li, K., Meng, J., Ren, G., Xin, T., Liu, Z., Wu, X., Wu, Y., Xue, Y., Zhu, G., Li, Z., Ge, S., Feng, D., …, & Zhao, T. (2026). Targeting astrocytic Dp71 attenuates BBB disruption after traumatic brain injury through WTAP-associated m 6 A regulation of MMP2. Science Advances, 12(27). https://doi.org/10.1126/sciadv.aed8653
Vancouver
Wang J, Zhao C, Liu B, Wang Z, Hou Y, Chen Y, et al. Targeting astrocytic Dp71 attenuates BBB disruption after traumatic brain injury through WTAP-associated m 6 A regulation of MMP2. Science Advances. 2026;12(27). doi:10.1126/sciadv.aed8653
BibTeX
@article{Wang2026,
author = {Wang, Jiheng and Zhao, Chenzhu and Liu, Bei and Wang, Zhuoyang and Hou, Yueru and Chen, Yuankun and Cui, Wenxing and Li, Kailu and Meng, Jinyuan and Ren, Ge and Xin, Tao and Liu, Zihao and Wu, Xun and Wu, Yingxi and Xue, Yafei and Zhu, Gang and Li, Zhihong and Ge, Shunnan and Feng, Dayun and Qu, Yan and Zhao, Tianzhi},
title = {Targeting astrocytic Dp71 attenuates BBB disruption after traumatic brain injury through WTAP-associated m 6 A regulation of MMP2},
journal = {Science Advances},
year = {2026},
volume = {12},
number = {27},
doi = {10.1126/sciadv.aed8653}
}
EUVIMED